KRTX
Karuna Therapeutics Inc
Price:  
329.83 
USD
Volume:  
1,868,420.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KRTX EV/EBITDA

-162.3%
Upside

As of 2025-05-29, the EV/EBITDA ratio of Karuna Therapeutics Inc (KRTX) is -25.17. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. KRTX's latest enterprise value is 12,397.19 mil USD. KRTX's TTM EBITDA according to its financial statements is -492.49 mil USD. Dividing these 2 quantities gives us the above KRTX EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 11.2x - 13.5x 13.3x
Forward P/E multiples 16.7x - 30.7x 19.3x
Fair Price (210.71) - (168.89) (205.55)
Upside -163.9% - -151.2% -162.3%
329.83 USD
Stock Price
(205.55) USD
Fair Price

KRTX EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA